Absorption |
Blood-Brain Barrier | BBB+ | 0.9797 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8716 |
P-glycoprotein Substrate | Substrate | 0.6450 |
P-glycoprotein Inhibitor | Inhibitor | 0.5368 |
Non-inhibitor | 0.6636 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7169 |
Distribution |
Subcellular localization | Mitochondria | 0.6523 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8327 |
CYP450 2D6 Substrate | Non-substrate | 0.9182 |
CYP450 3A4 Substrate | Substrate | 0.7666 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8755 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9389 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9235 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6569 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7129 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5506 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8343 |
Non-inhibitor | 0.7190 |
AMES Toxicity | Non AMES toxic | 0.9406 |
Carcinogens | Non-carcinogens | 0.9335 |
Fish Toxicity | High FHMT | 0.9887 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9942 |
Honey Bee Toxicity | High HBT | 0.8560 |
Biodegradation | Not ready biodegradable | 0.9606 |
Acute Oral Toxicity | IV | 0.6285 |
Carcinogenicity (Three-class) | Non-required | 0.4725 |